
ISO 10993-1 and Biocompatibilty Requirements for Medical Devices
As a global safety science leader, UL Solutions helps companies to demonstrate safety, enhance sustainability, strengthen security, deliver quality, manage risk and achieve regulatory compliance.
See how we put safety science to work to help create a safer, more secure and sustainable world for you.
Explore our business intelligence-building digital tools and databases, search for help, review our business information, or share your concerns and questions.
Accelerate your planning process and learn the requirements needed to take your products to market worldwide.
A secure, online source for increased visibility into your UL Solutions project files, product information, documents, samples and services.
Access UL certification data on products, components and systems, identify alternatives and view guide information with Product iQ.
ULTRUS™ helps companies work smarter and win more with powerful software to manage regulatory, supply chain and sustainability challenges.
Understand the structure and requirements of the latest ISO 10993-1 version
The U.S. Food and Drug Administration (FDA) requires device manufacturers seeking pre-market approval under its 510(k) program to submit testing data verifying the biocompatibility of any device or material that comes in direct or indirect contact with a patient. Yet, according to the FDA, as many as one-third of 510(k) submissions provide inadequate information regarding device biocompatibility, or failed to provide any biocompatibility data at all. For device manufacturers, these shortcomings often result in the rejection of a 510(k) submission or best case, an extended delay in its review by the FDA.
Modern medical devices are comprised of a diverse range of materials and components, each with their own unique physical and chemical characteristics. Although many of these materials present a minimal risk when incorporated into products intended for general use, their inclusion in medical devices significantly expands the scope of potential safety considerations. These can include the leaching of device materials due to heat or wear during normal operation or the migration of chemicals from the device.
In this white paper by UL, we’ll provide an overview of the structure and requirements presented in the latest version of ISO 10993-1 and provide details on the biological safety evaluation process set forth in Annex B of the standard.
ISO 10993-1 and Biocompatibilty Requirements for Medical Devices